Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||PAA165994/EX653 / 1||LA / -|
Administered by: Other Purchased by: ??
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Diagnostic Lab Data:
CDC 'Split Type': IEPFIZER INC2021654953
Write-up: Faint post vaccination; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer (patient) reported that a 24-year-old male patient received bnt162b2 (COMIRNATY, Lot# Paa165994/EX6537), dose 1 via an unknown route of administration administered at the age of 24-year-old on arm left on 04Jun2021 14:00 as 1ST DOSE, SINGLE for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. The patient experienced faint post vaccination on 04Jun2021 14:00 with outcome of recovered. No treatment received.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166